Patient Testimonial: Melissa, Cancer Signal Detected

Melissa made annual Galleri testing part of her routine health screening. In this patient testimonial, Melissa shares why recurring annual screening with the Galleri multi-cancer early detection test became important to her, and how one blood test can help screen for a cancer signal across more than 50 types of cancers, including many that do not have recommended screening tests today. When a cancer signal is detected, Galleri is designed to predict the Cancer Signal Origin, which can help healthcare providers understand where to look next and guide follow-up diagnostic testing. Melissa’s story is a powerful reminder that early detection can start with being proactive, staying consistent, and talking with your healthcare provider about whether Galleri is right for you. Learn more about MCED testing: https://grail.com https://galleri.com Galleri should be used in addition to healthcare provider recommended screening tests. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. Based on a clinical study of people ages 50 to 79 around 1% are expected to receive a Cancer Signal Detected result, which includes a predicted Cancer Signal Origin. After diagnostic evaluation, around 62% of these people are expected to have a confirmed cancer diagnosis. The overall sensitivity in study participants with liver/bile duct cancer was 93.5% (100% for stage I, 70.0% stage II, 100% stage III, 100% stage IV). Rx only. See Important Safety Information: https://www.galleri.com/safety